Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

WHAT DO WE ALREADY KNOW ABOUT THIS SUBJECT?

Breast milk (BM) is recognised as the best choice for feeding infants, especially those with a very-low-birth-weight (VLBW), i.e. <1,250 g. In intensive care units, when breastfeeding is impossible, it is recommended using pasteurised human breast milk (PHBM) donated from a breast-milk bank. BM or PHBM often requires enrichment to ensure optimal growth. Bovinemilk- based fortifiers (BMBFs) have traditionally been used for enrichment; however, more recently, human-milk-based fortifiers (HMBFs) are also used. While it is well established that VLBW infants have abnormal gut microbiota, it is not known how to improve the composition of this gut microbiota with the nutrients used in VLBW infants.

Clinical studies are needed to determine the impact of these different enrichments on the gut microbiota of VLBW infants.

WHAT ARE THE MAIN INSIGHTS FROM THIS STUDY?

The OptiMom randomised controlled trial included 119 infants with a birth weight <1,250g (56 BMBFs and 63 HMBFs). The median term and birth weight were 880 g and 27.9 weeks, with no differences in any of the parameters between the two groups. HMBF infants had lower microbial diversity (Shannon index) (p <0.005). A predominance of Proteobacteria and Firmicutes was observed in both groups, with a higher relative abundance of Proteobacteria (p = 0.0003) including unclassified Enterobacteriaceae (p = 0.005) and a lower abundance of Firmicutes (p = 0.001) including Clostridium stricto sensu (p = 0.04) in HMBFs compared to BMBFs (Figure 1). Bacterial abundance increased steadily over time in the BMBF group but changed little in the HMBF group (p = 0.03). The relative abundance of Clostridium stricto sensu (p = 0.04) was higher in BMBF infants compared to HMBF infants, and unclassified Enterobacteriaceae were lower (p = 0.005)(Figure 2). After normalising the abundance of taxa, other differences emerged on a genus level with higher concentrations of unclassified Eubacteriaceae (p <0.0001), Streptococcus (p = 0.0002) and Staphylococcus (p = 0.002), and lower concentrations of Clostridium stricto sensu (p = 0.04) in HMBF infants compared to BMBF infants. These changes in bacterial abundance were associated with changes in microbial function. Finally, it was possible to predict the type of fortifier received based on microbial abundance in stools.

The authors were interested in the effects of milk volumes. In both groups, higher volumes of BM for three days were associated with higher alpha diversity but were unrelated to total bacterial density. With higher BM volumes, a higher relative and normalised abundance of Veillonella was observed in both groups, and Streptococcus in the BMBF group. A positive link between BM volumes and Staphylococcus concentrations was observed in the HMBF group, and with unclassified Eubacteriaceae in the BMBF group.

PHBM volumes were only associated with higher diversity in the BMBF group and bacterial density. Similarly, lower relative and standardised abundances of unclassified Eubacteriaceae, Streptococcus and higher abundance of Clostridium stricto sensu were reported in BMBF infants with higher PHBM volumes.

Higher volumes of BMBF were positively related to bacterial diversity and density in the BMBF group but not in the HMBF group. BMBF volumes were positively associated with relative and standardised abundances of Firmicutes and Clostridium stricto sensu, whereas HMBF volumes were positively associated with relative and standardised abundances of Clostridium stricto sensu and negatively associated with Staphylococcus.

WHAT ARE THE CONSEQUENCES IN PRACTICE?

This study shows the importance of understanding the impact of the different nutrients used in the gut microbiota of VLBW infants to achieve a beneficial effect on their shortand long-term health.